TABLE 1.
N | Article (2020) |
Author (reference) |
Sex |
Age (years) |
Laterality of SSNHL |
4‐frequency PTA (dB) | Treatment | Outcome after reported FU |
---|---|---|---|---|---|---|---|---|
1 | May | Karimi (3) | M | 22 | Left | 0 ‐ 0 – 30 ‐ 40 | Unknown | Unknown |
2 | May | Karimi (3) | F | 40 | Right | 50 ‐ 60 ‐ 60 ‐ 60 | Unknown | Unknown |
3 | May | Karimi (3) | F | 23 | Left | 30 ‐ 35 ‐ 35 ‐ 40 | Unknown | Unknown |
4 | June | Degen (4) | M | 60 | Bilateral | Unknown |
Urgent cochlear implantation (Right), 3 IT injections (Left) |
Unknown |
5 | June | Kilic (5) | M | 29 | Right | 50 ‐ 40 ‐ 20 ‐ 10 | Hydroxychloroquine | Complete hearing recovery |
6 | September | Lang (6) | F | 30 | Right | 15 ‐ 10 ‐ 95 ‐ 80 | Oral prednisolone | No significant improvement |
7 | September | Koumpa (7) | M | 45 | Left | Unknown | Oral prednisolone and 3 IT injections | Partial improvement |
8 | September | Lamounier (8) | F | 67 | Right | 60 ‐ 85 ‐ 75 ‐ 75 | Oral prednisolone and 5 IT injections | Isolated recovery at 250Hz |
The audiometric data of the hearing loss at onset are reported as 4‐frequency pure‐tone average at respectively 500Hz ‐ 1000Hz ‐ 2000Hz ‐ 3000 or 4000Hz frequencies.
Abbreviations: dB, Decibels; F, Female; FU, Follow‐up period; Hz, Hertz; IT, Intratympanic corticoid; M, Male; N, Number; PTA, pure‐tone average; SNHL, Sensorineural hearing loss.